Robust Optimization of Antimicrobial Dosing Strategies in Multidrug-Resistant Klebsiella pneumoniae Infections

Abstract

The global rise in multidrug-resistant Klebsiella pneumoniae infections poses a significant clinical challenge. This study evaluates the efficacy of advanced pharmacokinetic models in optimizing antimicrobial dosing strategies. We employed a computational framework that integrates patient-specific data to predict optimal dosing regimens, thereby enhancing treatment outcomes. Results indicate a marked improvement in bacterial eradication rates and a reduction in adverse side effects, suggesting a paradigm shift in infectious disease management.